AbCellera Biologics Inc. (ABCL) Social Stream



AbCellera Biologics Inc. (ABCL): $5.00

0.09 (+1.83%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

D

Add ABCL to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#238 of 359

in industry

ABCELLERA BIOLOGICS INC (ABCL) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ABCL.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 4 $55 $25 $45.25 $5.08 790.75%
2021-12-05 5 $53 $25 $40.8 $5.08 703.15%
2021-12-19 7 $53 $25 $39.833 $5.08 684.11%
2021-12-21 7 $53 $25 $38 $5.08 648.03%
2022-02-11 5 $45 $25 $33 $5.08 549.61%
2022-02-25 5 $40 $20 $30 $5.08 490.55%
2022-05-09 5 $40 $20 $29.6 $5.08 482.68%
2022-05-11 5 $32 $14 $24.8 $5.08 388.19%
2022-08-09 5 $32 $14 $23.6 $5.08 364.57%
2022-08-11 5 $34 $14 $24 $5.08 372.44%
2022-10-23 5 $34 $13 $23.8 $5.08 368.5%
2022-11-02 4 $34 $13 $23.6 $5.08 364.57%
2022-11-09 5 $32 $20 $23.6 $5.08 364.57%
2022-11-30 6 $32 $20 $24.5 $5.08 382.28%
2022-12-15 7 $32 $20 $25.285 $5.08 397.74%
2023-01-06 6 $32 $18 $25 $5.08 392.13%
2023-02-21 7 $32 $18 $25 $5.08 392.13%
2023-02-22 7 $32 $18 $25.5 $5.08 401.97%
2023-04-20 7 $32 $16 $26.833 $5.08 428.21%
2023-05-04 7 $32 $15 $25.833 $5.08 408.52%
2023-05-11 7 $32 $15 $25.666 $5.08 405.24%
2023-05-26 7 $32 $15 $26.166 $5.08 415.08%
2023-08-03 7 $32.001 $15 $26.166 $5.08 415.08%
2023-08-07 7 $32.001 $13 $25.833 $5.08 408.52%
2023-08-31 8 $32 $12 $23 $5.08 352.76%

The Trend in the Analyst Price Target


ABCL's average price target has moved down $16.83 over the prior 21 months.

Over the past 45 weeks, ABCL's average upside potential has been 209.33%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-11-09 6 32.000 20 23.600 11.81 99.83%
2023-02-22 8 32.000 18 26.142 8.79 197.41%
2023-02-22 8 32.000 18 25.500 8.79 190.1%
2023-04-20 7 32.000 16 26.833 7.12 276.87%
2023-07-21 7 32.001 15 26.166 7.85 233.32%

ABCL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 8 0 0 0 0 8

The Trend in the Broker Recommendations


Over the past 43 weeks, ABCL's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • ABCL has a greater upside potential (average analyst target price relative to current price) than 3600.3% of all US stocks.
  • ABCELLERA BIOLOGICS INC's number of analysts covering the stock is greater than 325.16% of stocks in the large market cap category.
  • ABCL has a higher average analyst price target than 619.88% of stocks in the large market cap category.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, ABCELLERA BIOLOGICS INC's variance in analysts' estimates is lower than -2774.18% of them.

In the Pharmaceutical Products industry, RVMD, BEAM, and VIR are the three stocks most similar to ABCELLERA BIOLOGICS INC regarding the price target and analyst recommendation information presented here.

Is ABCL a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!